Macrophages have also been engineered to express BiTEs (bispecific T-cell engager) to facilitate the interactions of T cells and tumor cells via binding of a CD3ε and GBM-specific EGFRvIII (epidermal growth factor variant)86. Here, EGF is linked to neoplasm.